Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating Intermittent Dosing of Aspirin for Colorectal Cancer Chemoprevention

NCT02965703 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT02965703
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02965703 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating Intermittent Dosing of Aspirin for Colorectal Cancer Chemoprevention
Lead sponsor
National Cancer Institute (NCI)
Phase
Phase 2
Overall status
Active, not recruiting
Start date
January 16, 2018
Completion date
December 24, 2026
Enrollment
81 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal adenoma, colorectal carcinoma